Enanta Pharmaceuticals
ENTA
#8679
Rank
ยฃ0.18 B
Marketcap
ยฃ6.33
Share price
-4.02%
Change (1 day)
-34.99%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): -ยฃ1.80

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ1.83. In 2025 the company made an earnings per share (EPS) of -ยฃ2.43 an increase over its 2024 EPS that were of -ยฃ3.76.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.80-25.75%
2025-ยฃ2.43-35.35%
2024-ยฃ3.76
2021-ยฃ3.7872.92%
2020-ยฃ2.19-267.44%
2019ยฃ1.31-61.35%
2018ยฃ3.38147.22%
2017ยฃ1.37-460%
2016-ยฃ0.38-114.88%
2015ยฃ2.55-23.81%
2014ยฃ3.35-244.12%
2013-ยฃ2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.07-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.99-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.44-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ11.90-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.75-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.43-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA